In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Nordic Capital sells, then re-buys Nycomed Holding

Executive Summary

Investment bank Nordic Capital has entered into a definitive agreement to sell Nycomed Holding AS (the old Nycomed Pharma; pharmaceutical in-licensing and development) to a new investment company owned by CSFB Private Equity, Blackstone Capital Partners, and NIB Capital Private Equity. The purchase price is approximately $1.1bn, roughly 2 times Nycomed's 2001 sales, and is split evenly between debt and equity.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Buy-out
    • Full Acquisition
    • Payment Includes Cash

Related Companies